Abivax |
Biotechnology · Immunology & Inflammation Therapeutics

Abivax | news and milestones

Abivax |: 10 headlines on record, 7 headlines in the last 90 days. Its story counts 6 milestones.

Data updated Nov 20, 2026 · Back to the company report
10Headlines
7In 90 days
6Milestones

Newsroom

top 6%Web presenceof 133.2M domains by links, Common Crawl

Headlines

Sep 262026
News · YahooFinance
ABIVAX Société Anonyme (NASDAQ:ABVX) reported first-half 2026 operating cash use of €102.5 million on September 21, up from €66.6 million a year earlier. The roughly 54% increase…
Sep 232026
Press release · The Globe and Mail
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Sep 232026
News · Pulse 2.0
Abivax, a clinical-stage biotechnology company developing treatments for chronic inflammatory diseases, reported its first-half 2026 financial results and announced several leade…
Sep 222026
News · RTTNews
Abivax SA (ABVX, ABVX.PA), a clinical-stage biotechnology company, reported first-half 2026 financial results, reflecting a wider net loss, and provided an update on near-term mi…
Sep 222026
News · markets.businessinsider.com
Abivax Presents Business Updates and First Half 2026 Financial Results Chris Rabbat to succeed Fabio Cataldi as Chief Medical Officer; Tim Kelly a...
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Abivax |, News. Alion, Nov 20, 2026. https://alion.io/company/abivax/news

.json · .md · CC BY-SA 4.0